National Medical Care Co. (Care) reported a net profit of SAR 85.4 million in Q1 2025, a 5% growth from SAR 81.3 million in Q1 2024.
Item | Q1 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 298.56 | 385.32 | 29.1 % |
Gross Income | 110.20 | 142.98 | 29.7 % |
Operating Income | 71.05 | 96.55 | 35.9 % |
Net Income | 81.29 | 85.37 | 5.0 % |
Average Shares | 44.85 | 44.85 | - |
Earnings Per Share before unusual items (Riyal) | 1.46 | 1.90 | 30.4 % |
EPS (Riyal) | 1.81 | 1.90 | 5.0 % |
Item | Q4 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 372.54 | 385.32 | 3.4 % |
Gross Income | 124.23 | 142.98 | 15.1 % |
Operating Income | 44.44 | 96.55 | 117.2 % |
Net Income | 87.19 | 85.37 | (2.1 %) |
Average Shares | 44.85 | 44.85 | - |
Earnings Per Share before unusual items (Riyal) | 1.00 | 1.90 | 90.3 % |
EPS (Riyal) | 1.94 | 1.90 | (2.1 %) |
The earnings were propelled by higher revenue, more efficient operations across the company’s facilities, and favorable expected credit loss (ECL) expenses, due to reversals resulting from recoveries and settlements with insurance companies.
These gains were, however, offset by higher general and administrative expenses (G&As) related to the newly acquired assets, ongoing efforts to strengthen the company’s head office team, reduced other income, and increased financing costs.
On a sequential basis, net profit fell 2.1% from SAR 87.19 million in Q1 2024.
Total shareholders’ equity, no minority interest, rose to SAR 1.71 billion as of March 31, 2025, compared to SAR 1.53 billion a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: